Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ · Healthcare
Xeris Biopharma Holdings, Inc. Revenue 2020–2025
Xeris Biopharma Holdings, Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Xeris Biopharma Holdings, Inc. revenue for the quarter ending March 31, 2026 was 83.1 M, a 38.27% increase year-over-year.
- Xeris Biopharma Holdings, Inc. revenue for the twelve months ending March 31, 2026 was 289.2 M, a 51.16% increase year-over-year.
- Xeris Biopharma Holdings, Inc. annual revenue for 2025 was 291.8 M, a 43.72% increase from 2024.
- Xeris Biopharma Holdings, Inc. annual revenue for 2024 was 203.1 M, a 23.89% increase from 2023.
- Xeris Biopharma Holdings, Inc. annual revenue for 2023 was 163.9 M, a 48.68% increase from 2022.
- Xeris Biopharma Holdings, Inc. annual revenue for 2022 was 110.2 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Xeris Biopharma Holdings, Inc. Earnings — FAQ
Xeris Biopharma Holdings, Inc. (XERS) earnings over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XERS's earnings history?
The chart and table above show Xeris Biopharma Holdings, Inc.'s earnings by year and by quarter, including the growth rate.